Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendationsJeremy Hobart, Alan J. Thompson, Stefan Cano et al.|The Lancet Neurology|2007Cited by 497
What sample sizes for reliability and validity studies in neurology?Jeremy Hobart, Alan J. Thompson, Stefan Cano et al.|Journal of Neurology|2012Cited by 198
Factors influencing work retention for people with multiple sclerosisRory J O’Connor, E. Diane Playford, Stefan Cano et al.|Journal of Neurology|2005Cited by 114
Capturing the true burden of dystonia on patientsStefan Cano, Jeremy Hobart, Thomas T. Warner et al.|Neurology|2004Cited by 99
Patient Experience in Early-Stage Parkinson’s Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome AssessmentThomas Morel, Karlin Schroeder, Sophie Cleanthous et al.|Neurology and Therapy|2022Cited by 45